Evidence map›Paper›PMID 32485673›Full record

ArticleEndocrine connections2020

Positive association between progestins and the evolution of multiple fibroadenomas in 72 women.

Virginie Grouthier, Zeina Chakhtoura, Isabelle Tejedor, Yasmina Badachi, Vincent Goffin, Philippe Touraine

Open access · goldAbstract read
In one paragraph

Article in Endocrine connections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Virginie GrouthierDepartment of Endocrinology and Reproductive Medicine, GH La Pitié-Salpêtrière Charles-Foix, Center for Rare Gynecological Diseases, Paris, France.
Zeina ChakhtouraDepartment of Endocrinology and Reproductive Medicine, GH La Pitié-Salpêtrière Charles-Foix, Center for Rare Gynecological Diseases, Paris, France.
Isabelle TejedorDepartment of Endocrinology and Reproductive Medicine, GH La Pitié-Salpêtrière Charles-Foix, Center for Rare Gynecological Diseases, Paris, France.
Yasmina BadachiDepartment of General Radiology, GH La Pitié-Salpêtrière Charles-Foix, Paris, France.
Vincent GoffinInserm U1151 - CNRS UMR 8253, Institut Necker Enfants Malades (INEM), Faculté de Médecine Paris Descartes, Paris, France.
Philippe TouraineDepartment of Endocrinology and Reproductive Medicine, GH La Pitié-Salpêtrière Charles-Foix, Center for Rare Gynecological Diseases, Paris, France.
Hôpital Charles-Foix · FRSorbonne Université · FRInstitut Necker Enfants Malades · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMultiple fibroadenomas (MFA) of the breast is a rare benign disease, thus its natural history is poorly understood. The aim of our study was to describe the radiological evolution of MFA and to evaluate the influence of different factors on this evolution.

methodsThis was a longitudinal cohort study. All patients included had two clinical and radiological assessments (breast ultrasound (US) and/or MRI) at least 5 years apart.

resultsSeventy-two women were followed for 7.6 ± 2.1 years. The radiological evolution showed a decrease or stability in the number of fibroadenomas (FA) in 26/44 cases on the MRI and in 38/64 cases on the US. There was a decrease of size in 35/44 cases on the MRI and in 53/64 cases on the US. An increase in the number of FAs was found in 18/44 cases in the MRI and 26/64 cases in the US with, for the majority, a decrease of size (19/26 by MRI and 16/18 by MRI). Older age at the first FA (P < 0.0001) and at the diagnosis of MFA (P < 0.0001), pregnancy (P = 0.003) and progestin use (P < 0.001), particularly lynestrenol (P < 0.0001), had a beneficial effect on the evolution of MFA.

conclusionThis is the first longitudinal study describing women with MFA. The radiological evolution of MFA seamed favorable and similar to that expected for a single FA. We identified factors influencing the evolution of the disease, including progestin treatments such as lynestrenol, which could have a beneficial effect. Our cohort should be followed further in order to expand our knowledge of MFA, especially concerning the risk of breast cancer.

Indexed as

breastfeedingcontraceptionfibroadenomaspregnancyprogestins

Identifiers

PMID32485673
PMCPMC7354733
OpenAlexW3030329686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.